SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-140701
Filing Date
2023-05-10
Accepted
2023-05-10 16:07:06
Documents
85
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d499325d10q.htm   iXBRL 10-Q 1021499
2 EX-31.1 d499325dex311.htm EX-31.1 10166
3 EX-31.2 d499325dex312.htm EX-31.2 10151
4 EX-32.1 d499325dex321.htm EX-32.1 4050
5 EX-32.2 d499325dex322.htm EX-32.2 4050
  Complete submission text file 0001193125-23-140701.txt   6180671

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230331.xsd EX-101.SCH 65174
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20230331_cal.xml EX-101.CAL 52786
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20230331_def.xml EX-101.DEF 217625
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230331_lab.xml EX-101.LAB 431735
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230331_pre.xml EX-101.PRE 347242
79 EXTRACTED XBRL INSTANCE DOCUMENT d499325d10q_htm.xml XML 997280
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 23906344
SIC: 2834 Pharmaceutical Preparations